Definitive Healthcare Corp. (NASDAQ:DH) Receives $11.31 Consensus Target Price from Analysts

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been given a consensus rating of “Hold” by the nine ratings firms that are covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $11.31.

A number of brokerages recently commented on DH. Canaccord Genuity Group raised their price target on Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Canaccord Genuity Group cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Barclays raised their price target on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research report on Friday, March 1st. Stifel Nicolaus decreased their target price on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Wednesday, January 17th. Finally, Needham & Company LLC cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, January 17th.

Institutional Trading of Definitive Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Arizona State Retirement System grew its holdings in shares of Definitive Healthcare by 13.6% during the fourth quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock worth $142,000 after purchasing an additional 1,701 shares during the last quarter. Global Retirement Partners LLC grew its holdings in shares of Definitive Healthcare by 86.0% during the third quarter. Global Retirement Partners LLC now owns 4,171 shares of the company’s stock worth $31,000 after purchasing an additional 1,928 shares during the last quarter. OLD National Bancorp IN lifted its stake in shares of Definitive Healthcare by 14.5% in the third quarter. OLD National Bancorp IN now owns 20,613 shares of the company’s stock worth $165,000 after acquiring an additional 2,609 shares during the period. Corton Capital Inc. lifted its stake in shares of Definitive Healthcare by 17.0% in the third quarter. Corton Capital Inc. now owns 19,964 shares of the company’s stock worth $160,000 after acquiring an additional 2,898 shares during the period. Finally, Swiss National Bank boosted its holdings in Definitive Healthcare by 3.4% in the third quarter. Swiss National Bank now owns 96,900 shares of the company’s stock valued at $774,000 after acquiring an additional 3,200 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Stock Down 7.2 %

Shares of NASDAQ DH opened at $6.73 on Tuesday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare has a 52 week low of $5.53 and a 52 week high of $12.45. The stock has a market capitalization of $792.73 million, a P/E ratio of -3.78, a PEG ratio of 6.33 and a beta of 1.39. The stock’s fifty day moving average is $8.16 and its 200 day moving average is $8.29.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Sell-side analysts forecast that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.